Dr Reddys Laboratories files Annual Report with SEC

Dr Reddys Laboratories announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements prepared under International Financial Reporting Standards (IFRS), as issued by International Accounting Standards Board (IASB), for the fiscal year ended 31 March, 2022 was filed with the United States Securities and Exchange Commission on 27 June 2022.

Powered by Capital Market - Live News